Navigation Links
GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
Date:9/16/2009

NEW YORK, NY, Sept. 16 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed an engagement agreement with PacificWave Partners Limited ("PacWave") for raising a minimum of USD5m to the company as well as actively look for potential buy-out and/or acquisition targets.

The deal will entail an upcoming visit to the US where the management team will be meeting hedge funds and institutional investors, PacWave is confident that with the strength of the management team as well as the liquidity in the company's stock that financing can be secured within a timely fashion and under very favorable terms.

In addition to the fund raising effort, PacWave will approach a number of major pharma companies which are currently active making acquisitions of smaller biotech companies and position GENova as a potential next acquisition target.

About PacificWave Partners Limited

PacificWave Partners is a privately held international financial advisory firm providing investment banking services to privately-held and publicly-traded micro, small and mid capitalization companies throughout Asia, Europe and North America. PacificWave is headquartered in Copenhagen, Denmark with offices in San Francisco, Los Angeles and New York and specializes in capital raises between USD5m - USD50m

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pf
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GENova and TheraGlass in advanced negotiations
2. GENova Biotherapeutics forming academic partnerships
3. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
4. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
5. GENova gains access to Big Pharma
6. GENova appoints Dr. Wang Chong to Scientific Advisory Board
7. GENova appoints Dr. Philip Gould to Scientific Advisory Board
8. GENova issues clarifying press release
9. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
10. GENova files patent for new breast cancer treatment
11. GENova appoints Director of Asian business development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... (PRWEB) April 27, 2015 Final Cut ... of footage with ProTelestrator from Pixel Film Studios. A telestrator ... freehand sketch over a moving or still video image. Telestrators ... and analyze sports plays or incoming weather patterns. , After ... and then adjust the frame slider to control the speed ...
(Date:4/27/2015)... April 27, 2015 PREVENT Life Safety, ... its Texas operations with the addition of an account ... safety services to a growing customer base, Curtis Rice, ... a new Senior Account Manager. Curtis has been added ... existing customers throughout the Houston area and beyond. ...
(Date:4/27/2015)... April 27, 2015 Launched by ... engineer, ZendyBeauty offered consumers a way to connect ... affordable prices. Using a patent-pending Pick Your Price ... procedures like Botox®, laser hair removal and dermal ... staff had gaps in their schedules. This allows ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... Indiana Fiber Network, LLC (IFN), the leading ... Insurance Company has selected IFN as a fiber transport ... Brotherhood Mutual Insurance Company states: “IFN’s broadband fiber solution ... needed. We were interested in building entrance ... to ensure we achieved both. ” , ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:ZendyBeauty Is Pleased to Announce the Expansion and Rebranding of the Company as ZendyHealth.com 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 2Health News:Brotherhood Mutual Insurance Company Selects Indiana Fiber Network, LLC for Fiber Transport Service 3
... the United States Gulf Coast poses health risks to volunteers, ... a new commentary by UCSF researchers who spent time in ... health problems caused by the oil spill. The good ... factors, coastal air quality, is improving now that the oil ...
... dependent a man is on his female partner, the more ... to be presented at the 105th Annual Meeting of the ... to have the opposite effect: the more dependent they are ... engage in infidelity," said Christin Munsch, a sociology Ph.D. candidate ...
... 2010) Once thought to be a problem primarily in,the developed ... disability,in poorer countries. Almost two-thirds of the 7.6 million cancer ... A paper to be published online in the Lancet ... now discard the notion that cancer is,a ,disease of the ...
... congestion. Postnasal drip. Fatigue. These are hallmark ... nasal and sinus cavity. The illness strikes millions of Americans ... patients visit their primary care doctor. Treating sinusitis is difficult ... is viral or bacterial. Unfortunately little information on the ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... early trial, deep brain stimulation appeared to improve memory ... The authors caution that the findings are very preliminary ... from the study. However, test results and brain imaging ...
... Jenifer Goodwin HealthDay Reporter , FRIDAY, Aug. ... who regularly take acetaminophen, best known as Tylenol, were ... teens who never take the over-the-counter pain and fever ... linked to an increased chance of eczema and rhinoconjunctivitis, ...
Cached Medicine News:Health News:Health impact of Gulf Coast oil spill hazardous but improving 2Health News:Health impact of Gulf Coast oil spill hazardous but improving 3Health News:Men more likely to cheat if they are economically dependent on their female partners 2Health News:Global health leaders advocate for expanding cancer care in developing countries 2Health News:Global health leaders advocate for expanding cancer care in developing countries 3Health News:Primary care doctors get little information about chronic sinusitis 2Health News:Deep Brain Stimulation Studied for Alzheimer's 2Health News:Deep Brain Stimulation Studied for Alzheimer's 3Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 2Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 3Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 4
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... , April 24, 2015  Elekta has CE marked ... treatment planning system , enabling European clinics to deliver ... treatment techniques including advanced 3D planning, IMRT, VMAT and ... Monaco ® ... improved workflow efficiency. Advancements in 3D planning as well ...
(Date:4/23/2015)... Corporation (NYSE: EW ), the global leader in ... reported net income for the quarter ended March 31, 2015 ... income for the same period a year earlier was ... net income was $82.1 million, or $0.76 per diluted ... March 31, 2015 increased 13.0 percent to $590.3 million compared ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Elekta CE marks for Monaco v5.10 treatment planning system 2Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
... 12 A new study being,published in this Friday,s ... causes Parkinson,s disease?, One of the most pressing ... causes the sensitive cells in the brain to die,in ... difficult,because there are two nearly identical types of brain ...
... - New Data from Open Label Study and New Data ... HAE Screening Presented at ACAAI 2008 Annual Meeting ... VPHM ) today announced the presentation of data from its ... successfully treated all types of acute hereditary angioedema (HAE),attacks seen ...
Cached Medicine Technology:A Window Into Parkinson's Disease 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
... The Wet-Field Coagulator provides precise ... reduced peripheral tissue trauma. Controlled Rf ... most comprehensive line of bipolar Eraser ... combines enhanced features that ensure a ...
... Cauteries provide a broad selection ... in a wide variety of ... cautery is packaged sterile, complete ... lock switch in the "off ...
Medicine Products: